Molly Stevens is currently Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Institute of Biomedical Engineering at Imperial College. She joined Imperial in 2004 after postdoctoral training in tissue engineering with Professor Robert Langer in the Chemical Engineering Department at the Massachusetts Institute of Technology. Prior to this she graduated from Bath University with a First Class Honours degree in Pharmaceutical Sciences and was awarded a PhD in biophysical investigations of specific biomolecular interactions and single biomolecule mechanics from the University of Nottingham (2000). In 2010 she was recognised by The Times as a top ten scientists under the age of 40 and also received the Polymer International-IUPAC award for creativity in polymer science, the Rosenhain medal and the Norman Heatley Prize for Interdisciplinary research from the Royal Society of Chemistry, in addition to numerous previous awards. She has a large and multidisciplinary research group focussed on high quality fundamental science and translation for human health; research in her group can be described as tissue engineering, regenerative medicine, and nanotechnology. She is the co-founder of two spin-out companies, RepRegen and InTiGen.
Molly has developed novel approaches to tissue engineering that are likely to prove very powerful in the engineering of large quantities of human mature bones as well as other vital organs. For these innovations she won the Polymer International-IUPAC award in 2010.